Patent details
EP1695701 Title: HFA suspension formulations comprising an anticholinergic agent
Basic Information
- Publication number:
- EP1695701
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP061155081
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- German
- English Title of Invention:
- HFA suspension formulations comprising an anticholinergic agent
- French Title of Invention:
- Formulations de suspension contenant un gaz propulseur HFA et un anticholinergique
- German Title of Invention:
- HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
- SPC Number:
Dates
- Filing date:
- 20/03/2003
- Grant date:
- 07/01/2015
- EP Publication Date:
- 07/01/2015
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 30/08/2006
- EP B1 Publication Date:
- 07/01/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 20/03/2015
- Expiration date:
- 20/03/2023
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/03/2003
- Name:
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Address:
- A Patente Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)
Inventor
- Name:
- Schmelzer Dr., Christel
- Address:
- Germany (DE)
Priority
- Priority Number:
- 10214263
- Priority Date:
- 28/03/2002
- Priority Country:
- Germany (DE)
Classification
- Main IPC Class:
- A61K 9/72;
| Filing date | Document type | Number of pages |
|---|